Companion Diagnostics Markets: Forecasts to 2018 (Cancer, Cardiovascular and Blood, Metabolic, Infection, Neurological, Others)

Companion Diagnostics Markets (Cancer, Cardiovascular and Blood, Metabolic, Infection, Neurological, Others)

Companion drug/test products are of great interest to pharmaceutical companies, testmakers, as well as investors and entrpreneurs. The global market is increasing, and test/product development is increasing as an area of development for pharma companies. Many companion products are now successfully marketed, especially for cancer treatment. Several are part of routine diagnostic and treatment.

This report explains events in the market and provides lists of companion products. It also provides market sizing and forecasts models for companies engaged in the market or those who are assessing its potential.

This report, Companion Diagnostics Markets tracks these new developments and focuses on companion diagnostics in medicine in 2013 and 2014. The report provides product analysis for the five broad areas of medical companion diagnostics and market information, with forecasts to 2018

Infectious Disease
Neurological Disorders
Oncology
Blood
Metabolic
Cardiovascular

The situation with compainion diagnotics is fluid. Uptake was because companion tests lacked FDA approval, which prevented promotion But the realization that companion diagnostics can cut costs will most likely benefit from a therapy and ruling out those therapies has ensured a pathway.

There are many competitors in the market which include large multiproduct companies such as Siemens, Roche and Beckman Coulter and small niche developers such as Diagenic 20/20 GeneSystems.

Companies profiles in this report include:

• 20/20 GeneSystems
• Abbott Laboratories
• Affymetrix
• Agendia
• Alere
• Beckman Coulter
• Becton Dickinson
• Biocartis SA
• Biodesix
• bioMerieux
• BioReference Laboratory
• bioTheranostics
• CardioDX
• Celera Alameda
• Clarient
• deCODE Genetics
• DiaGenic
• Genomic Health
• Genoptix Medical Laboratory
• Illumina
• Johnson & Johnson
• Life Techologies
• Memory Dx
• Myriad Genetics
• Nanostring Technologies
• OPKO Health
• Provista Dx
• Qiagen
• Roche
• Seimens Healthcare
• Singulex
• Thermo Fisher Scientific

The analysis presented in this report is based on data from a combination of company, government, industry, institutional and private sources. It includes information from secondary sources and interviews with experts. including research scientists, business development managers and marketing managers.microbiologists, pathologists, hospital authorities and reimbursement specialists.